Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer

PURPOSE: Estrogen receptor (ER) expression is a prognostic parameter in breast cancer, and a prerequisite for the use of endocrine therapy. In ER(+) early breast cancer, however, no receptor-associated biomarker exists that identifies patients with a particularly favorable outcome. We have investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Christian F., Holst, Frederik, Steurer, Stefan, Burandt, Eike C., Lax, Sigurd F., Jakesz, Raimund, Rudas, Margaretha, Stöger, Herbert, Greil, Richard, Sauter, Guido, Filipits, Martin, Simon, Ronald, Gnant, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475247/
https://www.ncbi.nlm.nih.gov/pubmed/35920686
http://dx.doi.org/10.1158/1078-0432.CCR-21-4328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475247/
https://www.ncbi.nlm.nih.gov/pubmed/35920686
http://dx.doi.org/10.1158/1078-0432.CCR-21-4328

Ejemplares similares